Merck S.A. (Central America & Caribbean)
Merck, S.A. Guatemala was established in 1971. Our operations embrace Central America (El Salvador, Honduras, Costa Rica, Nicaragua, Panama, Belize) the Caribbean (Curacao, Aruba, Trinidad & Tobago, Jamaica, Bahamas, Barbados, Haiti, Puerto Rico) and also Dominican Republic and Cuba.
| Facts & Figures | |
| Managing Director | Gerardo Blasberg |
| Number of employees | In Guatemala: 180; in the region: 100 |
| Major products -Pharma | Oncology (Erbitux®, UFT®), neurodegenerative diseases (Rebif®), fertility (Gonal-F®, Ovidrel®, Pergoveris), endocrinology (Saizen®, Serostim®), cardiometabolic care (Glisulin, Glisulin XR, Glucovance, Zatium, Ziac, Concor®, Eutirox®, Cilostal, Encefabol); primary care (family of Neurobion®, Calozán, Flogozán, Perenterol, Enzypride, Movipride, Ambril, Arliv, Denvar); Consumer Health Care (Cebión®, Diabión®, Iliadin); other therapheutic areas. |
| Major products -Chemicals | Performance & Life Science Chemicals:
|
